Description
| Item ID # | 47768900 |
| Manufacturer # | 2434892 |
| Brand | |
Antimuscarinic / Antispasmodic Ipratropium Bromide 0.02%, 0.2 mg / mL Unit Dose, Inhalation Solution Vial 30 Vials
UOM CARTON/30
$8.28
10000 in stock
Related products
-
#73038900 Mfr#Depo-Medrol® Corticosteroid Methylprednisolone Acetate 40 mg / mL Injection Single Dose Vial 1 mL
Features
- Sterile Aqueous Suspension
- DEPO-MEDROL is an anti-inflammatory glucocorticoid for intramuscular, intraarticular, soft tissue or intralesional injection
- Not for intravenous use
-
#58198900 Mfr#Fluarix® Quadrivalent Flu Vaccine 60 mcg / 0.5 mL Users 3 Years and Older Prefilled Syringe 0.5 mL
Features
- FLUARIX QUADRIVALENT is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
- FLUARIX QUADRIVALENT is approved for use in persons 3 years of age and older
-
#64968909 Mfr#Zostavax® Shingles Vaccine Varicella – Zoster Virus Vaccine, Live, Attenuated. Preservative Free 19400 Unit / 0.65 mL Injection Single Dose Vial 0.65 mL
Features
- ZOSTAVAX* is supplied as follows: (1) a package of 10 single-dose vials of lyophilized vaccine, NDC 0006-4963-41 (package A); and (2) a separate package of 10 vials of diluent (package B)
- ZOSTAVAX* is stored frozen and should be reconstituted immediately upon removal from the freezer
- The diluent should be stored separately at room temperature (20 to 25 degrees celcius, 68 to 77 degrees fahrenheit), or in the refrigerator (2 to 8 degrees celcius, 36 to 46 degrees fahrenheit)
-
#58908900 Mfr# 589-05Menactra® Meningitis Vaccine Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Preservative Free 4 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL
Features
- Menactra is indicated for active immunization of individuals 2 through 55 years of age for the prevention of invasive meningococcal disease
- Menactra vaccine is administered as a 0.5 mL dose by intramuscular injection
- In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart